Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
The efficacy and safety of a new reduced-toxicity conditioning with 4 days of once-daily 100 mg/m(2) intravenous busulfan associated with fludarabine and antithymocyte globulins prior to allogeneic stem cell transplantation in patients with high-risk myelodysplastic syndrome or acute leukemia
Over the course of a research program involving multiple orders, the cumulative savings from free shipping are substantial
CoreVionRX guarantees a minimum purity of 99%+ on all KLOW batches
Premium-priced due to the delivery technology
The proble
US$ 21.41
US$ 27.66
US$ 25.28
US$ 23.76
US$ 27.39
US$ 25.73
US$ 29.12
